GlaxoSmithKline Pharmaceuticals Limited has submitted a regulatory disclosure to BSE Limited and The National Stock Exchange of India Limited regarding the distribution of its Annual Report for the financial year ended 31st March 2026.

The disclosure consists of two letters:

Letter to Stock Exchanges (dated 8th June 2026):

  • Submitted by Ajay Avinash Nadkarni, Vice President – Administration, Real Estate & Company Secretary
  • Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 36(1)(b)
  • Company has issued letters to shareholders whose email addresses are not registered with the Company/Depository Participants
  • These letters provide a weblink from where the Annual Report can be accessed on the Company's website
  • An enclosed letter to shareholders was provided to the exchanges

Letter to Shareholders (dated 6th June 2026):

  • Addressed to shareholders without registered email addresses with Depository Participants/Registrar and Transfer Agent (RTA)
  • Annual Report for FY ended 31st March 2026 has been emailed to shareholders with registered email addresses
  • For shareholders without registered email, the company provides web-link: https://india-pharma.gsk.com/en-in/investors/annual-reports/
  • Mandatory SEBI requirements highlighted: shareholders must update PAN, KYC details (including postal address with pin code, email address, mobile number, bank account details), and nomination details
  • Payments including dividends will only be made electronically upon registration of required information for folios where PAN or KYC details are not updated
  • Special mention of Senior Citizens Investor Cell formed by RTA, Kfintech Technologies Limited:
  • Exclusively assists shareholders who are senior citizens (above 60 years of age)
  • Helps redress grievances, complaints, and queries
  • Communication address: senior.citizen@kfintech.com
  • Dedicated toll-free number: 1800 3094 006
  • General queries should be directed to RTA at einward.ris@kfintech.com

Financial Impact

No specific financial impact disclosed. The notification pertains to administrative and compliance matters regarding annual report distribution and shareholder communication.